Matilde Otero-Losada
Overview
Explore the profile of Matilde Otero-Losada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bordet S, Grasso L, Udovin L, Chevalier G, Otero-Losada M, Capani F, et al.
Mov Disord Clin Pract
. 2025 Jan;
PMID: 39825674
Background: The cerebral Renin-Angiotensin System might have a role in anxiety and depression development. Objective: We explored the effects of Angiotensin II Type 1 receptor blockers (ARBs) and angiotensin-converting enzyme...
2.
Toro-Urrego N, Luaces J, Kobiec T, Udovin L, Bordet S, Otero-Losada M, et al.
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596189
Perinatal asphyxia (PA) is a clinical condition characterized by oxygen supply suspension before, during, or immediately after birth, and it is an important risk factor for neurodevelopmental damage. Its estimated...
3.
Kobiec T, Mardaraz C, Toro-Urrego N, Kolliker-Frers R, Capani F, Otero-Losada M
Front Neurosci
. 2023 Sep;
17:1279346.
PMID: 37746138
[This corrects the article DOI: 10.3389/fnins.2023.1214468.].
4.
Otero-Losada M, Marseglia A, Blanco Calvo E, Capani F
Front Neurosci
. 2023 Sep;
17:1263570.
PMID: 37655009
No abstract available.
5.
Bordet S, Luaces J, Herrera M, Gonzalez L, Kobiec T, Perez-Lloret S, et al.
Front Neurosci
. 2023 Aug;
17:1215041.
PMID: 37650104
Based on clinical and experimental evidence, metabolic syndrome (MetS) and type 2 diabetes (T2D) are considered risk factors for chronic cerebral hypoperfusion (CCH) and neurodegeneration. Scientific evidence suggests that protein...
6.
Kobiec T, Mardaraz C, Toro-Urrego N, Kolliker-Frers R, Capani F, Otero-Losada M
Front Neurosci
. 2023 Aug;
17:1214468.
PMID: 37638319
Metabolic syndrome (MetS) is defined by the concurrence of different metabolic conditions: obesity, hypertension, dyslipidemia, and hyperglycemia. Its incidence has been increasingly rising over the past decades and has become...
7.
Perez-Lloret S, Chevalier G, Bordet S, Barbar H, Capani F, Udovin L, et al.
Brain Sci
. 2023 Aug;
13(8).
PMID: 37626502
Patients with Parkinson's Disease (PD) experience REM sleep behavior disorder (RBD) more frequently than healthy controls. RBD is associated with torpid disease evolution. To test the hypothesis that differential genetic...
8.
Chevalier G, Udovin L, Otero-Losada M, Bordet S, Capani F, Luo S, et al.
Brain Sci
. 2023 Mar;
13(3).
PMID: 36979316
The genetic basis of Neurogenic Orthostatic Hypotension (NOH) in Parkinson's disease (PD) has been inadequately explored. In a cross-sectional study, we examined the association between NOH and PD-related single-nucleotide polymorphisms...
9.
Otero-Losada M, Gubellini P, Capani F, Perez-Lloret S
Front Pharmacol
. 2023 Jan;
13:1121513.
PMID: 36699074
No abstract available.
10.
Loureiro D, Bilbao R, Bordet S, Grasso L, Otero-Losada M, Capani F, et al.
Neurol Sci
. 2023 Jan;
44(4):1479.
PMID: 36646860
No abstract available.